Skip to content

Clinical trials

Hypercholesterolemia trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Country / region: Sweden Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20063
20071
20082
20114
20122
20137
20142
20162
20173
20181
20191
20202
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen11
Sanofi6
Kowa Research Europe4
Karo Bio AB3
Novartis Pharmaceuticals3
Karolinska Institutet2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Kastle Therapeutics, LLC1
Raisio Group1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia35
Dyslipidemias12
Hyperlipidemias6
Cardiovascular Diseases3
Atherosclerosis2
Coronary Artery Disease2
Coronary Disease1
Coronary Stenosis1
Homozygous Familial Hypercholesterolemia1
Hyperlipoproteinemia Type II1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.